Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Hair Follicle Secretome and PRP for Premature Ovarian Insufficiency
NCT07916740Phase 2Recruiting
- Sponsor
- Trio Fertility
- Start
- Sep 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in premature ovarian insufficiency (POI), sponsored by Trio Fertility. Primary endpoints: Change in Serum Follicle-Stimulating Hormone Levels at 3 months, Change in Serum Anti-Müllerian Hormone Levels at 3 months and 1 more. Started Sep 2025; status: recruiting.
02
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT07916740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07916740.